New drug fights Alzheimer disease.
The FDA has approved a rivastigmine transdermal patch for mild to moderate Alzheimer disease. The Exelon Patch[R] (Novartis) is the first transdermal system approved to treat Alzheimer disease. The patch also has been approved for mild to moderate Parkinson disease dementia. Rivastigmine oral formulations
Transdermal patches should be applied immediately after being removed from their outer packaging and should never be cut into smaller pieces. The Exelon Patch should be removed after 24 hours and a new patch should be applied. Application sites should be rotated. Make sure all transdermal patches and medications are disposed of properly and out of reach of children and pets. The most common side effects reported in a trial of Exelon Patch were gastrointestinal symptoms, such as nausea and vomiting, that are typical of all cholinesterase inhibitors. For more information on the Exelon patch, visit www.exelon.com.
Email this Article
Digg It
del.icio.usRelated Articles
- MICRONEEDLES Offer Painless Delivery.
- More help in getting rid of the evil weed.
- Alzheimer's and HRT.
- Delivering estrogen after menopause.
- The forgetful mourner.
- Tapemark announces organizational changes.
- Novel delivery of pigment-lightening agents on the way.
- Racing abroad this summer?
- Patch streamlines ADHD management.
- Transdermal estradiol may be an effective antidepressant. ('Quite Rapid' Onset).
- ADHD patch: label reflects sensitization concerns.
- NEW WAYS to Take MEDICINE.
- Alzheimer Disease.
- 'Reckless abandon' in use of estrogen therapy results in discipline.
- Prescribing of HRT Poised for Shift.
Microneedles much thinner than the diameter of a human hair could be the basis for a new drug delivery technique able to administer small quantities of high-potency medications through the skin without causing pain. Arrays of the microneedles could improve ......
MORE HELP IN GETTING RID OF THE EVIL WEED Smokers who are trying to kick the habit (and we hope they are many!) may find help in an interesting product that has just come on the market. Called Nicoderm, the ......
Dear AFI: Do you have any information as to whether there is a link between HRT and the risk of Alzheimer Disease? My mother has Alzheimer's and I take HRT.--S.Y. AFI: In recent, well-designed studies, it appears that women on ......
Physicians have a new means of providing relief to postmenopausal women experiencing vaginal discomfort. Estring, a soft, flexible ring for insertion into the vagina. releases a slow, continuous dose of estradiol, an estrogen produced by the ovaries, that lasts for ......
Mrs. C, an eighty-six-year-old Italian American woman, is moderately demented due to Alzheimer disease. She had been living with her son Tony and his wife Isabella but when Tony suffered a heart attack two years ago, everyone agreed that it ......
Tapemark Company, a contract manufacturer based in West St. Paul, MN, announced that Tom Yetter is now serving as the company's vice president of research and development, and Kim Mueller has assumed the position of vice president of sales and ......
ORLANDO, FLA. -- Penetration-enhancing sunscreens combined with hydroquinone mark the latest attempt to effectively deliver pigment-lightening agents to specific areas, Dr. Zoe Draelos reported at a cosmetic dermatology seminar sponsored by the Skin Disease Education Foundation. UVB sunscreens, specifically octyl ......
as more people seek out international running events or book adventure vacations abroad, it's worth exploring guidelines for active international travel. Before you leave the country, ask your doctor or a travel medicine specialist which vaccinations are appropriate for your ......
Children with attention-deficit/hyperactivity disorder who wore Daytrana methylphenidate transdermal patches for stretches of 4 or 6 hours showed improvements in their symptoms, according to results from a multicenter controlled trial. A prior study showed improvements in symptoms of 2-12 hours ......
ALBUQUERQUE -- Transdermal estradiol appears to be an effective antidepressant in penmenopausal women with various forms of depression, Dr. Paula Hensley said at a psychiatric symposium sponsored by the University of New Mexico. But that doesn't mean it's time to ......
The Food and Drug Administration has approved Daytrana, a methylphenidate patch for the treatment of attention-deficit hyperactivity disorder in children aged 6-11 years. The approval had been widely expected after an FDA advisory subcommittee endorsed the patch earlier this year ......
When it comes to delivering medications, patches, EpiPens, inhalers, and even microchips are catching up with pills. Joey started wheezing soon after entering Mike's house. "Uh oh, you must have a cat," Joey gasped. He reached into his pocket, grabbed ......
Alzheimer Disease 2nd ed, edited by Robert D. Terry, Robert Katzman, Katherine L. Bick, and Sangram S. Sisodia, 457 pp, with illus, Philadelphia, Pa, Lippincott Williams & Wilkins, 1999. This is an excellent multiauthored text with chapters covering clinical presentations, ......
CASE ON POINT: HAW V. IDAHO STATE BOARD OF MEDICINE, 2004 WL 856801 P.2D-ID. ISSUE: Boards of Medical Licensure and Discipline must deal with the bad apples of the medical profession. In this extraordinary Idaho case, the State's Board of ......
SOUTH LAKE TAHOE, NEV. -- The large number of new products in development for hormone replacement therapy portends a dramatic shift in the way hormone replacement is prescribed. No woman will stay with a single regimen indefinitely, Dr. Maida Taylor ......